These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23311002)

  • 21. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C.
    Rakov NE
    N Engl J Med; 2003 Jan; 348(3):259-60; author reply 259-60. PubMed ID: 12529472
    [No Abstract]   [Full Text] [Related]  

  • 22. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
    Hu CC; Chien RN
    Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
    [No Abstract]   [Full Text] [Related]  

  • 23. Summaries for patients. Re-treating patients with chronic hepatitis C who have not responded to peginterferon-alpha2b.
    Ann Intern Med; 2009 Apr; 150(8):I-34. PubMed ID: 19380849
    [No Abstract]   [Full Text] [Related]  

  • 24. Peginterferon and ribavirin for hepatitis C.
    Assy N; Embon O
    N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17380576
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
    Rou WS; Lee BS
    Clin Mol Hepatol; 2015 Jun; 21(2):122-4. PubMed ID: 26157748
    [No Abstract]   [Full Text] [Related]  

  • 26. Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following PEG-interferon and ribavirin treatment.
    Aladag M; Camci C; Huang Y; Wright H; Rizvi S; Gurakar A; Stokes K; Sebastian A
    J Clin Gastroenterol; 2005; 39(10):923-4. PubMed ID: 16208125
    [No Abstract]   [Full Text] [Related]  

  • 27. [Importance of medication adherence to peginterferon-ribavirin combination therapy in patients with chronic hepatitis C].
    Goh PG; Kim MJ; Kim HJ; Eun HS; Kim ES; Kim YJ; Lee SY; Moon HS; Lee ES; Kim SH; Lee BS; Lee HY
    Korean J Gastroenterol; 2011 May; 57(5):294-301. PubMed ID: 21623138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peginterferon alpha-2a and ribavirin for treating chronic hepatitis C patients with persistent normal aminotransferase levels].
    Jiang TJ; Fan R; Xie YX; Zhao P; Zhang X; Zhao M; Zhou ZP; He J
    Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):307-8. PubMed ID: 18423159
    [No Abstract]   [Full Text] [Related]  

  • 29. Ribavirin with interferon for hepatitis C in dialysis patients: efficacious and safe in the right patients in good hands.
    Mutimer D
    Gut; 2015 Feb; 64(2):190-1. PubMed ID: 24861270
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection.
    Kim TY
    Korean J Hepatol; 2012 Mar; 18(1):29-31. PubMed ID: 22511900
    [No Abstract]   [Full Text] [Related]  

  • 31. Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-a2a/ribavirin in combination with a direct-acting anti-viral.
    Mishra A; Younossi Z
    Aliment Pharmacol Ther; 2013 Sep; 38(5):557-8. PubMed ID: 23937466
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?
    Hu KQ; Zhang YY
    J Clin Gastroenterol; 2014 Jan; 48(1):3-5. PubMed ID: 24045272
    [No Abstract]   [Full Text] [Related]  

  • 33. [A 72 week follow-up study of chronic hepatitis C patients treated with peginterferon alfa-2b and ribavirin].
    Yu SL; Zhang ZH; Lv H; Zhang QG; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):231. PubMed ID: 17407724
    [No Abstract]   [Full Text] [Related]  

  • 34. Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.
    Hauser G; Awad T; Thorlund K; Štimac D; Mabrouk M; Gluud C
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005642. PubMed ID: 24585451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spotlight on peginterferon-alpha-2a (40 kD) plus ribavirin in the management of chronic hepatitis C mono-infection.
    Keam SJ; Cvetković RS
    BioDrugs; 2009; 23(1):63-8. PubMed ID: 19344193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels.
    Brillanti S; Levantesi F; Nigro G; Vicari S; Roda E
    Ann Intern Med; 2003 Dec; 139(11):W83. PubMed ID: 14644911
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum lipid profile and chronic hepatitis C virus.
    Purnak T; Efe C; Beyazit Y; Ozaslan E
    Hepatology; 2011 Feb; 53(2):716-7. PubMed ID: 20890943
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of chronic Hepatitis C in 2008].
    Niederau C; Kaden T
    MMW Fortschr Med; 2008 Mar; 150(13):31-4. PubMed ID: 18522354
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in treatment of chronic hepatitis C: 'pegylated' interferons.
    Sharieff KA; Duncan D; Younossi Z
    Cleve Clin J Med; 2002 Feb; 69(2):155-9. PubMed ID: 11990646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection.
    Lin CC; Wu CH; Chen HL; Lin IT; Wang SY; Wang TE; Wang HY; Shih SC; Bair MJ
    Ann Hepatol; 2014; 13(4):350-5. PubMed ID: 24927605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.